IN2014MU00386A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00386A
IN2014MU00386A IN386MU2014A IN2014MU00386A IN 2014MU00386 A IN2014MU00386 A IN 2014MU00386A IN 386MU2014 A IN386MU2014 A IN 386MU2014A IN 2014MU00386 A IN2014MU00386 A IN 2014MU00386A
Authority
IN
India
Prior art keywords
salts
benzazepine
tetrahydro
chloro
methyl
Prior art date
Application number
Inventor
Shri Prakash Dhar Dwivedi
Jayprakash Ajitsingh Parihar
Alpesh Pravinchandra Shah
Samir Rameshbhai Gajjar
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN386MU2014 priority Critical patent/IN2014MU00386A/en
Publication of IN2014MU00386A publication Critical patent/IN2014MU00386A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NOVEL SALTS OF (R)-8-CHLORO-1-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE The present invention provides novel salts of the 5-HT2C-receptor agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (known as lorcaserin). The invention also provides to process for the prepration of these salts. Further the invention provides pharmaceutical compositions and dosage forms comprising therapeutically effective amount of the salts of the 5-HT2C-receptor agonist (R)-8-chloro-l-methyl-2,3,4,5-tetrahydro-lH-3-benzazepine, for weight management.
IN386MU2014 2014-02-04 2014-02-04 IN2014MU00386A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN386MU2014 IN2014MU00386A (en) 2014-02-04 2014-02-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN386MU2014 IN2014MU00386A (en) 2014-02-04 2014-02-04

Publications (1)

Publication Number Publication Date
IN2014MU00386A true IN2014MU00386A (en) 2015-09-25

Family

ID=54393764

Family Applications (1)

Application Number Title Priority Date Filing Date
IN386MU2014 IN2014MU00386A (en) 2014-02-04 2014-02-04

Country Status (1)

Country Link
IN (1) IN2014MU00386A (en)

Similar Documents

Publication Publication Date Title
NZ747259A (en) Soluble c5ar antagonists
PH12016501966B1 (en) Compounds and compositions as toll-like receptor 7 agonists
MX2018007704A (en) Pharmaceutical composition comprising amorphous lenalidomide and an antioxidant.
MY194262A (en) Inhibitors of ret
MX2019001096A (en) Tlr7/8 antagonists and uses thereof.
MY197700A (en) Compounds useful for inhibiting cdk7
NZ724878A (en) Compounds and compositions as toll-like receptor 7 agonists
TW201613859A (en) Analogs of PRIDOPIDINE, their preparation and use
MX2016011632A (en) Azaspiro derivatives as trpm8 antagonists.
MX2017000827A (en) Sugar compositions for tableting by direct compression.
JO3154B1 (en) Trpv4 antagonists
MX2017005484A (en) Dopamine d3 receptor antagonists compounds.
MX2021001786A (en) Integrin antagonists.
MX2015011536A (en) Novel sulfonamide trpa1 receptor antagonists.
MX2017001103A (en) Indolizine derivatives which are applicable to neurodegenerative diseases.
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX2018002446A (en) Fused heterocyclic compounds as s1p modulators.
NZ734400A (en) Amide compounds as 5-ht4 receptor agonists
IN2014CH00840A (en)
MX2017000829A (en) Sugar compositions for tableting by direct compression.
WO2015001541A3 (en) Pharmaceutical film composition
MX2017016939A (en) Novel 5-ht2 antagonists.
NZ741384A (en) Dopamine d3 receptor antagonists having a morpholine moiety
MX2017008983A (en) Sulfonamide pharmaceutical composition.
WO2016020408A3 (en) Compounds for preventing ototoxicity